Stay updated on Semaglutide in Heart Failure & Obesity: Clinical Trial
Sign up to get notified when there's something new on the Semaglutide in Heart Failure & Obesity: Clinical Trial page.

Latest updates to the Semaglutide in Heart Failure & Obesity: Clinical Trial page
- Check5 days agoChange DetectedA new revision tag, v3.3.3, was added to the history, and the HHS Vulnerability Disclosure link along with the previous revision tag v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe latest version adds updated Contacts/Locations and Study Status. It also removes the 2025-02-26 entry from the history.SummaryDifference0.2%

- Check26 days agoChange DetectedFooter revision updated to Revision: v3.3.2, replacing Revision: v3.3.1. This reflects a minor site update that does not affect study content or user-interactive features.SummaryDifference0.0%

- Check34 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.1 on the page footer. No study record details or history entries were altered in this update; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedThe government funding lapse notice was removed from the page. This change eliminates an administrative status banner without altering the core study information.SummaryDifference0.3%

- Check55 days agoChange DetectedTwo screenshots show minor UI/layout adjustments in the Study Record History page, with no visible changes to core trial data such as status, locations, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Semaglutide in Heart Failure & Obesity: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide in Heart Failure & Obesity: Clinical Trial page.